Clinical Trials Directory

Trials / Completed

CompletedNCT01497132

Effects of Vitamin D on Beta Cell Function and Insulin Sensitivity in Pre-diabetes and Diabetes Mellitus Type 2

Effects of Vitamin D on Beta Cell Function and Insulin Sensitivity in Pre-diabetes and Diabetes Mellitus Type 2 - EVIDENS

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
44 (actual)
Sponsor
Karolinska Institutet · Academic / Other
Sex
All
Age
45 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate if treatment with vitamin D increase beta cell function and insulin sensitivity in subjects with pre-diabetes or newly diagnosed diabetes mellitus type 2.

Conditions

Interventions

TypeNameDescription
DRUGVitamin D3Oral drops 30000 IU weekly
DRUGPlaceboMatching placebo

Timeline

Start date
2012-01-01
Primary completion
2013-05-01
Completion
2013-05-01
First posted
2011-12-22
Last updated
2014-09-10

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT01497132. Inclusion in this directory is not an endorsement.

Effects of Vitamin D on Beta Cell Function and Insulin Sensitivity in Pre-diabetes and Diabetes Mellitus Type 2 (NCT01497132) · Clinical Trials Directory